After an 83% crash, is this FTSE 250 stock in deep value territory?

Warren Buffett says the time to be greedy is when others are fearful. And Stephen Wright thinks it could be time to consider a FTSE 250 underperformer.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Person holding magnifying glass over important document, reading the small print

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Dr Martens (LSE:DOCS) has been a publicly-traded company for less than four years. But the FTSE 250 stock has fallen 83%, due to difficult trading conditions and a series of unforced errors.

Created with Highcharts 11.4.3Dr. Martens Plc PriceZoom1M3M6MYTD1Y5Y10YALL9 Jul 20199 Jul 2024Zoom ▾Jan '20Jul '20Jan '21Jul '21Jan '22Jul '22Jan '23Jul '23Jan '24Jul '242020202020212021202220222023202320242024www.fool.co.uk

The company still has its best asset – its brand – and a balance sheet that looks reasonably strong. So could this be the time to be greedy when others are fearful?

How bad’s the damage?

Dr Martens has had two main problems – weak consumer spending and poor execution of its e-commerce expansion. And the effects show up in the company’s financial position. 

Should you invest £1,000 in Amazon right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Amazon made the list?

See the 6 stocks

Inventory levels have increased from £123m in 2022 to £255m this year. While it shows up as an asset on the balance sheet, excess inventory isn’t something businesses want.

When a company has more products than it can sell, it has to work out how to store them. That’s expensive and rising costs are bad news for profitability.

On the liabilities side, Dr Martens has also seen its debt levels increase. Net debt has risen from £53m to £175m and interest payments rose from £17m to £31m.

As a result, interest payments now eat up 25% of the company’s operating income. At the start of 2022, it was 6%. 

Dr Martens is clearly in a worse position than it was when it first launched on the UK stock market. But there’s reason for thinking the share price might have fallen too far. 

Value territory

Arguably the main problem is weaker demand in the US. But this issue isn’t specific to the company and isn’t one it can directly do anything about.

Across the board, consumer discretionary businesses have been struggling with depressed consumer spending in the US. It’s the biggest reason shares in Nike are down 31% over the last year.

Created with Highcharts 11.4.3Nike PriceZoom1M3M6MYTD1Y5Y10YALL9 Jul 20199 Jul 2024Zoom ▾Jan '20Jul '20Jan '21Jul '21Jan '22Jul '22Jan '23Jul '23Jan '24Jul '242020202020212021202220222023202320242024www.fool.co.uk

At a price-to-earnings (P/E) ratio of 20, I think Nike shares are still some way from bargain territory. But the situation with Dr Martens might be different.

The stock currently trades at a P/E ratio of 11. And that’s based on earnings per share that have fallen 44% from where they were a couple of years ago.

If Doc Martens can get back to earning 18p per share, then the current share price implies a P/E ratio of 4. That’s a bargain by anyone’s standards, but it’s a big ‘if’. And there’s another issue.

The big question is when are things going to start improving? And management’s forecasting another weak year before this happens, meaning shareholders are going to have to wait for some time. 

A risk worth taking?

Weak US demand isn’t the only reason shares in Dr Martens have crashed since going public. But a macroeconomic recovery has the potential to turn the company’s fortunes around.

The big question is when this will happen. Management doubts that improvement is imminent, but investors with a long-term view might think the shares are worth considering. 

I think considering the stock at today’s prices could turn out to be a good decision, over time. But given the risks, I’d look to keep it as a part of a diversified portfolio.

AI Revolution Awaits: Uncover Top Stock Picks for Massive Potential Gains!

Buckle up because we're about to dive headfirst into the electrifying world of AI.

Imagine this: you make a single savvy investment in some cutting-edge technology, then kick back and watch as it revolutionises entire industries and potentially even lines your pockets.

If the mere thought of riding this AI wave excites you and the prospect of massive potential returns gets your pulse racing, then you’ve got to check out this Motley Fool Share Advisor report – 'AI Front Runners: 3 Surprising Stocks Riding The AI Wave’!

And here’s the kicker – we’re giving you an exclusive peek at ONE of these top AI stock picks, absolutely free! How’s that for a bit of brilliance?

Get your free AI stock pick

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Stephen Wright has no position in any of the shares mentioned. The Motley Fool UK has recommended Nike. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

At a 52-week low but forecast to rise 73%! Is this growth share the FTSE’s top recovery play? 

This FTSE 100 growth share has taken an absolute beating over the past two years but Harvey Jones says the…

Read more »

Investing Articles

This FTSE 250 share offers a juicy 9.8% yield. Will it last?

This well-known FTSE 250 share has a percentage dividend yield approaching double digits. Should Christopher Ruane add the income share…

Read more »

Investing Articles

Is a £333,000 portfolio enough to retire and live off passive income?

A third of a million pounds can generate a serious amount of passive income, but relying on this sum alone…

Read more »

The flag of the United States of America flying in front of the Capitol building
Investing For Beginners

Why FTSE 100 investors should pay attention to ‘Liberation Day’

Jon Smith explains why the upcoming tariff announcement from across the pond could have an impact on the FTSE 100,…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

Here’s why Nvidia stock fell 13% in March

The Nvidia stock price rise was looking unstoppable. Should investors now be wondering if the same might be true of…

Read more »

US Stock

It’s ISA deadline week! Here’s my 3-step game plan

Jon Smith tries to calm the hype around the last minute ISA rush to buy stocks and explains why he's…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

£10,000 invested in BAE Systems shares at Christmas is now worth…

BAE Systems shares have been surging in the FTSE 100 in 2025, driven higher by the wavering US commitment to…

Read more »

Investing Articles

Up 19% in 2 weeks, can the Tesla share price rebound further?

Tesla's first-quarter delivery numbers came out today. Will they help persuade our writer to invest his money at the current…

Read more »